TEVA - Teva Pharmaceutical Industries Limited
| Previous Close | 7.83 |
| Open | 7.87 |
| Bid | 7.90 x 36100 |
| Ask | 7.96 x 45900 |
| Day's Range | 7.76 - 8.00 |
| 52 Week Range | 7.67 - 25.96 |
| Volume | 17,185,191 |
| Avg. Volume | 18,491,896 |
| Market Cap | 8.721B |
| Beta (3Y Monthly) | 2.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.42 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2017-11-27 |
| 1y Target Est | 13.95 |
- Yahoo Finance•13 hours ago
Express Scripts, Novartis subsidiary probed in NJ amid fight over tax credit program
Tax breaks for two major health care companies are under scrutiny by New Jersey’s economic development agency.
- GlobeNewswire•5 hours ago
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BUD, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, July 19, 2019 -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:.
- ACCESSWIRE•12 hours ago
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CYH, ASNA and TEVA
NEW YORK, NY / ACCESSWIRE / July 19, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.
- GlobeNewswire•13 hours ago
ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
- ACCESSWIRE•16 hours ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BOX, TEVA and DBD
CEDARHURST, NY / ACCESSWIRE / July 19, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
- ACCESSWIRE•17 hours ago
Class Action - ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / July 19, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
- Zacks•2 days ago
3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement
Here are some of the highlights of J&J's (JNJ) second-quarter earnings call.
- GuruFocus.com•2 days ago
Bernard Horn Comments on Teva Pharmaceutical
Guru stock highlight Continue reading...
- ACCESSWIRE•2 days ago
SHAREHOLDER ALERT: HL TEVA FRED: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / July 18, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss ...
- GlobeNewswire•2 days ago
Barbuto & Johansson, P.A. reminds TEVA, EQT, FRED and RBGLY Shareholders of Class Action Deadlines
WELLINGTON, Fla., July 18, 2019 -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience,.
- GlobeNewswire•2 days ago
SHAREHOLDER ALERT: PYX BUD TEVA RBGLY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, July 18, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
- GlobeNewswire•2 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EROS, PSMT, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, July 17, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
- Zacks•3 days ago
Teva Pharmaceutical Industries Ltd. (TEVA) Dips More Than Broader Markets: What You Should Know
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.11 in the latest trading session, marking a -1.1% move from the prior day.
- ACCESSWIRE•3 days ago
CLASS ACTION UPDATE for TEVA, FDX and RBGLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / July 17, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- ACCESSWIRE•3 days ago
Class Action Update - ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / July 17, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
- Motley Fool•3 days ago
3 Drug Stocks With Unimaginably Low P/E Ratios
These drug developers are all valued at less than four times this year's projected earnings per share.
- MarketWatch•3 days ago
Opioid makers dumped 76 billion pills onto U.S. market over 7 critical years, data shows
Newly released federal data shows how drugmakers and distributors increased shipments of opioid painkillers across the U.S. as the nation’s addiction crisis accelerated from 2006 to 2012.
- ACCESSWIRE•3 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLDR, TEVA and FRED
CEDARHURST, NY / ACCESSWIRE / July 16, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
- GlobeNewswire•3 days ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pivotal Software, Inc., Eros International Plc, Teva Pharmaceutical Industries Ltd, and Helius Medical Technologies, Inc. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Class Period: Securities pursuant or traceable to Pivotal’s April 2018 initial public offering (“IPO”) and/or securities purchased or acquired between April 24, 2019 and June 4, 2019 (the “Class Period”).
- Zacks•4 days ago
Teva Shares Fall Further as Morgan Stanley Downgrades Rating
Shares of Teva (TEVA) are on a downtrend on the risk of high litigation costs related to opioid epidemic in the United States. Morgan Stanley downgrades its rating on Teva.
- Benzinga•4 days ago
Option Trader Makes Bullish Bet On Lannett Rebound
On Tuesday morning, Benzinga Pro subscribers received two options alerts related to Lannett. At 9:36 a.m., a trader bought 854 Lannett call options at a $7.50 strike price that expire on Sept. 20. At 9:42 a.m., likely the same trader bought another 752 Sept. 20 $7.50 Lannett call options at the ask price of 45.1 cents.
- ACCESSWIRE•4 days ago
CLASS ACTION UPDATE for EROS, TEVA and FRED: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / July 16, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- Zacks•4 days ago
J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View
J&J (JNJ) beats estimates for both earnings and sales in the second quarter of 2019 and raises 2019 guidance for operational sales growth for the second time this year.
- GlobeNewswire•4 days ago
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Ltd. (“Teva” or “the Company”) (NYSE: TEVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
- GlobeNewswire•4 days ago
CLASS ACTION UPDATE for BUD, TEVA, EQT and INS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, July 16, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
